| scholarly article | Q13442814 |
| P50 | author | Nicola Edwards | Q60672839 |
| P2093 | author name string | Fiona L Wilkinson | |
| M Yvonne Alexander | |||
| Alexander W W Langford-Smith | |||
| P2860 | cites work | Elevated plasma asymmetric dimethyl-L-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis | Q63184843 |
| Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy | Q63285824 | ||
| mTOR inhibition induces endothelial progenitor cell death | Q79780268 | ||
| Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes | Q79843154 | ||
| Glycomimetic drugs--a new source of therapeutic opportunities | Q82360729 | ||
| Effects of tumour necrosis factor-alpha on activity and nitric oxide synthase of endothelial progenitor cells from peripheral blood | Q84440262 | ||
| Comparative study on circulating endothelial progenitor cells in systemic lupus erythematosus patients at active stage | Q84763358 | ||
| Glycosaminoglycan mimetic improves enrichment and cell functions of human endothelial progenitor cell colonies | Q87555932 | ||
| MicroRNA-21 and the Vulnerability of Atherosclerotic Plaques | Q88151490 | ||
| Prostanoids for critical limb ischaemia | Q24240537 | ||
| Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review | Q26746063 | ||
| Vascular Ageing and Exercise: Focus on Cellular Reparative Processes | Q26772296 | ||
| Endothelial Progenitor Cells Physiology and Metabolic Plasticity in Brain Angiogenesis and Blood-Brain Barrier Modeling | Q28072654 | ||
| Epigenetic regulation of endothelial-cell-mediated vascular repair | Q28085420 | ||
| Comparison of Fibronectin and Collagen in Supporting the Isolation and Expansion of Endothelial Progenitor Cells from Human Adult Peripheral Blood | Q31122581 | ||
| The effect of type 1 IFN on human aortic endothelial cell function in vitro: relevance to systemic lupus erythematosus | Q33588015 | ||
| Mitochondria, endothelial cell function, and vascular diseases | Q33600464 | ||
| Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus | Q33659103 | ||
| Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation. | Q33678290 | ||
| Effect of vitamin D on endothelial progenitor cells function | Q33699531 | ||
| Cell Connections by Tunneling Nanotubes: Effects of Mitochondrial Trafficking on Target Cell Metabolism, Homeostasis, and Response to Therapy | Q33808890 | ||
| Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity | Q33873733 | ||
| Reprogramming of myeloid angiogenic cells by Bartonella henselae leads to microenvironmental regulation of pathological angiogenesis. | Q50592467 | ||
| Relationship of osteoprotegerin to pulse wave velocity and carotid intima-media thickness in rheumatoid arthritis patients. | Q50776302 | ||
| The atheroma plaque secretome stimulates the mobilization of endothelial progenitor cells ex vivo. | Q50880007 | ||
| Brief Report: Vitamin D Deficiency Is Associated With Endothelial Dysfunction and Increases Type I Interferon Gene Expression in a Murine Model of Systemic Lupus Erythematosus. | Q51655680 | ||
| Trichostatin A enhances vascular repair by injected human endothelial progenitors through increasing the expression of TAL1-dependent genes. | Q51738076 | ||
| Shear stress: An essential driver of endothelial progenitor cells. | Q52352341 | ||
| Age-related impairment of endothelial progenitor cell migration correlates with structural alterations of heparan sulfate proteoglycans. | Q52632093 | ||
| Endothelial progenitor cell secretome delivered by novel polymeric nanoparticles in ischemic hindlimb. | Q52661984 | ||
| Sustained Release of Endothelial Progenitor Cell-Derived Extracellular Vesicles from Shear-Thinning Hydrogels Improves Angiogenesis and Promotes Function after Myocardial Infarction. | Q52724942 | ||
| Neferine Protects Endothelial Glycocalyx via Mitochondrial ROS in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome. | Q52727749 | ||
| The multifaceted balance of TNF-α and type I/II interferon responses in SLE and RA: how monocytes manage the impact of cytokines. | Q52888237 | ||
| Accumulation of VEGFR-2+/CD133+ cells and decreased number and impaired functionality of CD34+/VEGFR-2+ cells in patients with SLE. | Q53355584 | ||
| Cell-to-Cell Connection of Endothelial Progenitor Cells With Cardiac Myocytes by Nanotubes | Q58816268 | ||
| Endothelial progenitor cell-derived microvesicles improve neovascularization in a murine model of hindlimb ischemia | Q58831464 | ||
| Reduced Vitamin D Receptor on Circulating Endothelial Progenitor Cells: A New Risk Factor of Coronary Artery Diseases | Q47412761 | ||
| Circulating endothelial cells and their progenitors in systemic lupus erythematosus and early rheumatoid arthritis patients. | Q47426474 | ||
| Endothelial transplantation rejuvenates aged hematopoietic stem cell function | Q47441774 | ||
| Endothelial Progenitor Cell Mobilization in Preterm Infants With Sepsis Is Associated With Improved Survival. | Q48127623 | ||
| Lower Resting and Exercise-Induced Circulating Angiogenic Progenitors and Angiogenic T-Cells in Older Men. | Q49789500 | ||
| Aging process, adherence to Mediterranean diet and nutritional status in a large cohort of nonagenarians: Effects on endothelial progenitor cells | Q49789929 | ||
| Puerarin protects endothelial progenitor cells from damage of angiotensin II via activation of ERK1/2‑Nrf2 signaling pathway | Q49849158 | ||
| Gender-differences in glycemic control and diabetes related factors in young adults with type 1 diabetes: results from the METRO study. | Q49891865 | ||
| Endothelial progenitor cells for cellular angiogenesis and repair: lessons learned from experimental animal models | Q50035033 | ||
| Epigenetic Activation of Pro-angiogenic Signaling Pathways in Human Endothelial Progenitors Increases Vasculogenesis | Q50071790 | ||
| Endothelial progenitor cells and vascular repair | Q33874692 | ||
| Gene expression profiling in circulating endothelial cells from systemic sclerosis patients shows an altered control of apoptosis and angiogenesis that is modified by iloprost infusion | Q34152945 | ||
| Aging is not associated with bone marrow-resident progenitor cell depletion | Q34171737 | ||
| Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients | Q34273836 | ||
| Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study | Q34469009 | ||
| Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. | Q34632614 | ||
| Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis | Q34672043 | ||
| Aging is associated with a proapoptotic endothelial progenitor cell phenotype. | Q35063592 | ||
| Tunneling nanotubes mediate rescue of prematurely senescent endothelial cells by endothelial progenitors: exchange of lysosomal pool | Q35188228 | ||
| Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8. | Q35286823 | ||
| Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus | Q35566819 | ||
| Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells | Q35636813 | ||
| Interleukin 10 hampers endothelial cell differentiation and enhances the effects of interferon α on lupus endothelial cell progenitors | Q35661943 | ||
| Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus | Q35672600 | ||
| Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number. | Q35737625 | ||
| Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease. | Q35821434 | ||
| Age and Smoking Related Changes in Metal Ion Levels in Human Lens: Implications for Cataract Formation | Q35900004 | ||
| Endothelial progenitor cell phenotype and function are impaired in childhood-onset systemic lupus erythematosus. | Q35901110 | ||
| Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus | Q35954549 | ||
| Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis | Q36059617 | ||
| Endothelial progenitor cells: a new player in lupus? | Q36084953 | ||
| Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis | Q36139902 | ||
| Elevated levels of endothelial-derived microparticles, and serum CXCL9 and SCGF-β are associated with unstable asymptomatic carotid plaques. | Q36275429 | ||
| Endothelial colony-forming cells ameliorate endothelial dysfunction via secreted factors following ischemia-reperfusion injury | Q36287886 | ||
| Vitamin D improves the angiogenic properties of endothelial progenitor cells. | Q36382400 | ||
| Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus | Q36392411 | ||
| Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis | Q36602763 | ||
| Vitamin D improves endothelial dysfunction and restores myeloid angiogenic cell function via reduced CXCL-10 expression in systemic lupus erythematosus | Q36634362 | ||
| Severe Type 2 Diabetes Induces Reversible Modifications of Endothelial Progenitor Cells Which are Ameliorate by Glycemic Control | Q37126579 | ||
| Effect of therapeutic inhibition of TNF on circulating endothelial progenitor cells in patients with rheumatoid arthritis. | Q37260123 | ||
| Aging decreases expression and activity of glutathione peroxidase-1 in human endothelial progenitor cells | Q37439217 | ||
| IFNα serum levels are associated with endothelial progenitor cells imbalance and disease features in rheumatoid arthritis patients | Q37500133 | ||
| Microparticle subpopulations are potential markers of disease progression and vascular dysfunction across a spectrum of connective tissue disease | Q37544731 | ||
| miR-193a-3p interaction with HMGB1 downregulates human endothelial cell proliferation and migration | Q37690178 | ||
| The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development | Q37734546 | ||
| Endothelial dysfunction in rheumatic autoimmune diseases | Q38016726 | ||
| Mitochondrial dysfunction and the inflammatory response | Q38075344 | ||
| Anti-interferon alpha treatment in SLE. | Q38097198 | ||
| Improving cardiovascular outcomes in rheumatic diseases: therapeutic potential of circulating endothelial progenitor cells | Q38170870 | ||
| The role of complement in age-related macular degeneration: heparan sulphate, a ZIP code for complement factor H? | Q38171012 | ||
| Complementing the Sugar Code: Role of GAGs and Sialic Acid in Complement Regulation | Q38362621 | ||
| Do adverse pregnancy outcomes contribute to accelerated cardiovascular events seen in young women with systemic lupus erythematosus? | Q38654271 | ||
| High glucose-induced endothelial progenitor cell dysfunction | Q38656088 | ||
| Mitochondrial Function in Engineered Cardiac Tissues is Co-Regulated by Extracellular Matrix Elasticity and Tissue Alignment. | Q38667230 | ||
| Endothelial microparticles prevent lipid-induced endothelial damage via Akt/eNOS signaling and reduced oxidative stress. | Q38688884 | ||
| Micro-RNAs in abdominal aortic aneurysms: insights from animal models and relevance to human disease | Q38769017 | ||
| Endothelial progenitor cells and hypertension: current concepts and future implications | Q38812640 | ||
| Vitamin D treatment for connective tissue diseases: hope beyond the hype? | Q38834399 | ||
| Update on cardiovascular disease in lupus | Q38844782 | ||
| Endothelial progenitor cells dysfunction and impaired tissue reparation: The missed link in diabetes mellitus development | Q38942046 | ||
| Modulating putative endothelial progenitor cells for the treatment of endothelial dysfunction and cardiovascular complications in diabetes | Q38988982 | ||
| Progenitor Cells for Arterial Repair: Incremental Advancements towards Therapeutic Reality. | Q39148627 | ||
| Mitochondria in endothelial cells: Sensors and integrators of environmental cues. | Q39266998 | ||
| Inflammation and mitochondrial dysfunction: A vicious circle in neurodegenerative disorders? | Q39408809 | ||
| Extracellular Vesicles, Tunneling Nanotubes, and Cellular Interplay: Synergies and Missing Links. | Q40097136 | ||
| Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease | Q40379249 | ||
| Microvesicles Derived from Indoxyl Sulfate Treated Endothelial Cells Induce Endothelial Progenitor Cells Dysfunction. | Q41688602 | ||
| TNFα-Damaged-HUVECs Microparticles Modify Endothelial Progenitor Cell Functional Activity | Q42001712 | ||
| Endothelial progenitor cells and plaque burden in stented coronary artery segments: an optical coherence tomography study six months after elective PCI | Q42290489 | ||
| Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization. | Q42456673 | ||
| Age-related decline in reendothelialization capacity of human endothelial progenitor cells is restored by shear stress. | Q42505646 | ||
| Dysfunction of endothelial progenitor cells is associated with the type I IFN pathway in patients with polymyositis and dermatomyositis | Q42726421 | ||
| Circulating Endothelial Progenitor Cells in Type 1 Diabetic Patients: Relation with Patients' Age and Disease Duration. | Q43461095 | ||
| Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes | Q43472325 | ||
| Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study | Q43807400 | ||
| Osteoprotegerin causes apoptosis of endothelial progenitor cells by induction of oxidative stress | Q44937839 | ||
| Endothelial function is associated with myocardial diastolic function in women with systemic lupus erythematosus. | Q45102525 | ||
| Impaired progenitor cell activity in age-related endothelial dysfunction | Q46464362 | ||
| Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. | Q46464366 | ||
| Advanced Glycation Endproducts Impair Endothelial Progenitor Cell Migration and Homing via Syndecan 4 Shedding. | Q46473033 | ||
| A novel role for small molecule glycomimetics in the protection against lipid-induced endothelial dysfunction: Involvement of Akt/eNOS and Nrf2/ARE signaling. | Q46497851 | ||
| Human endothelial colony-forming cells protect against acute kidney injury: role of exosomes. | Q46715111 | ||
| Review: Metabolic Control of Immune System Activation in Rheumatic Diseases | Q47133379 | ||
| Inhibition of Cyclooxygenase-2 Suppresses the Recruitment of Endothelial Progenitor Cells in the Microvasculature of Endometriotic Lesions | Q47386045 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 200 | |
| P577 | publication date | 2018-07-10 | |
| P1433 | published in | Frontiers in Medicine | Q27726181 |
| P1476 | title | Endothelial Progenitor Cells: New Targets for Therapeutics for Inflammatory Conditions With High Cardiovascular Risk | |
| P478 | volume | 5 |
| Q92798638 | Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway |
| Q64258287 | Diabetic endothelial colony forming cells have the potential for restoration with glycomimetics |
| Q64945420 | Endothelial Progenitor Cells and Cardiovascular Correlates. |
| Q90115248 | Identification of the initial molecular changes in response to circulating angiogenic cells-mediated therapy in critical limb ischemia |
Search more.